Veterinary Medicines

Suivac APP2 injektionsvæske, emulsion

Authorised
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, serotype 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX II toxoid
Download as PDF

Product identification

Medicine name:
Suivac APP2 injektionsvæske, emulsion
Active substance:
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, serotype 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX II toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, APX III toxoid
    5.50
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serotype 2, strain App2TR98, Inactivated
    5.50
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX II toxoid
    5.50
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chemvet Dk A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 66143
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."